New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 17, 2014
12:35 EDTHSP, CBSTHospira granted tentative approval for generic daptomycin
Hospira (HSP) was granted tentative approval for generic daptomycin, according to a post to the FDA's website dated June 16. Daptomycin is an antibiotic used in the treatment of infections caused by Gram-positive organisms that is sold under the trade name Cubicin by Cubist Pharmaceuticals (CBST). Reference Link
News For HSP;CBST From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 15, 2015
07:41 EDTHSPEBD Group to hold a forum
ChinaBio Partnering Forum 2015 is being held in Shanghai, China on April 15-16.
April 7, 2015
11:02 EDTHSPHospira responds to FDA warning letter
Subscribe for More Information
09:30 EDTHSPHospira sent FDA warning letter following site inspection
The FDA sent a warning letter to Hospira, dated March 31, following a May 5-9 and 12-13, 2014 inspection of the company's pharmaceutical manufacturing facility. "We have conducted a detailed review of your firmís response dated June 4, 2014 and note that it lacks sufficient corrective actions. We acknowledge receipt of your firmís correspondence dated August 4, 2014, October 2, 2014, December 4, 2014, and February 9, 2015," the FDA states in its letter. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use